US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vivani Medical, Inc.

1.15

+0.01000.88%

Post-market: 1.160.0085+0.74%16:21 EDT

Volume:63.10K

Turnover:72.41K

Market Cap:68.13M

PE:-2.75

High:1.16

Open:1.13

Low:1.13

Close:1.14

Loading ...

Overview Company News Filings

Vivani Medical Inc. Unveils Presentation on Innovative Drug Implants for Chronic Disease Management

Vivani Medical Inc. Announces Promising Results from Exenatide Implant Study, Showing 82% Liver Fat Reduction in Obese Mice

Vivani Medical Inc. Unveils Presentation on Innovative Drug Implants for Chronic Disease Treatment

Vivani Medical Appoints Anthony Baldor as Chief Financial Officer

THOMSON REUTERS

Vivani Medical Inc - Brigid a. Makes Retires as CFO of Vivani Medical

THOMSON REUTERS

Press Release: Vivani Medical Appoints Anthony Baldor as Chief Financial Officer

Vivani Medical Price Target Maintained With a $4.00/Share by HC Wainwright & Co.

Director and 10% Owner Gregg Williams Reports Acquisition of Common Shares in Vivani Medical Inc

Vivani Medical Inc. Unveils Investor Presentation Highlighting Innovative Drug Implant Programs for Chronic Disease Management

Vivani Medical Q1 EPS $(0.11) Misses $(0.10) Estimate

BRIEF-Vivani Medical Q1 Basic EPS USD -0.11

Vivani Medical Q1 Basic EPS USD -0.11

THOMSON REUTERS

Press Release: Vivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial Results

Vivani Medical Inc expected to post a loss of 10 cents a share - Earnings Preview

Director and 10% Owner Gregg Williams Reports Acquisition of Common Shares of Vivani Medical Inc

Vivani Medical, Okava Expand Weight-Loss Drug Collaboration to Include Dogs

MT Newswires Live

BRIEF-Vivani Medical And Okava Expand Collaboration To Develop Okv-119 For Dogs, Targeting Metabolic Health And Longevity

Vivani Medical Inc - Financial Terms of Expanded Agreement Not Disclosed

THOMSON REUTERS

Vivani Medical and Okava Expand Collaboration to Develop Okv-119 for Dogs, Targeting Metabolic Health and Longevity

THOMSON REUTERS

Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/VANI/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VANI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VANI\",,,,,undefined,":{"symbol":"VANI","market":"US","secType":"STK","nameCN":"Vivani Medical, Inc.","latestPrice":1.15,"timestamp":1750190400000,"preClose":1.14,"halted":0,"volume":63104,"hourTrading":{"tag":"盘后","latestPrice":1.1585,"preClose":1.15,"latestTime":"16:21 EDT","volume":401,"amount":464.54995870000005,"timestamp":1750191697320},"delay":0,"floatShares":30972594,"shares":59243903,"eps":-0.418562,"marketStatus":"Post-Mkt","change":0.01,"latestTime":"06-17 16:40:27 EDT","open":1.13,"high":1.16,"low":1.13,"amount":72410.6092,"amplitude":0.026316,"askPrice":1.24,"askSize":200,"bidPrice":1.04,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.418562,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1750204800000},"marketStatusCode":4,"adr":0,"listingDate":1416373200000,"exchange":"NASDAQ","adjPreClose":1.14,"preHourTrading":{"tag":"盘前","latestPrice":1.19,"preClose":1.14,"latestTime":"08:33 EDT","volume":45,"amount":53.670006,"timestamp":1750163601451},"postHourTrading":{"tag":"盘后","latestPrice":1.1585,"preClose":1.15,"latestTime":"16:21 EDT","volume":401,"amount":464.54995870000005,"timestamp":1750191697320},"volumeRatio":0.59107,"impliedVol":2.7819,"impliedVolPercentile":0.996},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VANI\",,,,,undefined,":{"symbol":"VANI","floatShares":30972594,"roa":"-35.03%","roe":"-117.76%","lyrEps":-0.427165,"volumeRatio":0.59107,"shares":59243903,"dividePrice":0,"high":1.16,"amplitude":0.026316,"preClose":1.14,"low":1.13,"week52Low":0.9054,"pbRate":"5.86","week52High":1.6,"institutionHeld":0,"latestPrice":1.15,"committee":-0.333333,"eps":-0.418562,"divideRate":0,"volume":63104,"delay":0,"ttmEps":-0.418562,"open":1.13,"prevYearClose":1.16,"prevWeekClose":1.15,"prevMonthClose":1.26,"prevQuarterClose":1.05,"fiveDayClose":1.17,"twentyDayClose":1.07,"sixtyDayClose":1.09},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VANI\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2544960513","title":"Vivani Medical Inc. Unveils Presentation on Innovative Drug Implants for Chronic Disease Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2544960513","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544960513?lang=en_us&edition=fundamental","pubTime":"2025-06-17 21:05","pubTimestamp":1750165531,"startTime":"0","endTime":"0","summary":"Vivani Medical Inc. has presented its 2025 Investor Presentation, highlighting its status as a clinical-stage biopharmaceutical company focused on the development of ultra long-acting, miniature drug implants for chronic diseases. The presentation details Vivani's NanoPortal platform technology, designed to enhance medication adherence and tolerability. Key programs include the NPM-115  and NPM-139  implants, targeting chronic weight management with once or twice-yearly dosing. The company also discusses its IND-cleared NPM-119  implant for type 2 diabetes, planned for twice-yearly dosing. Anticipated milestones in 2025 include the completion of the First-in-human, LIBERATE-1 trial and advancing the NPM-139 program toward clinical development. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250617:nNDL1KLMXZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VANI","BK4082"],"gpt_icon":0},{"id":"2544463965","title":"Vivani Medical Inc. Announces Promising Results from Exenatide Implant Study, Showing 82% Liver Fat Reduction in Obese Mice","url":"https://stock-news.laohu8.com/highlight/detail?id=2544463965","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544463965?lang=en_us&edition=fundamental","pubTime":"2025-06-17 18:16","pubTimestamp":1750155405,"startTime":"0","endTime":"0","summary":"Vivani Medical Inc. has announced promising results from their recent study involving an exenatide implant designed to reduce liver fat and manage body weight. The study, which was presented in a recent Form 8-K filing, demonstrated that the exenatide implant reduced liver fat by 82% in obese mice after 12 weeks. The findings were consistent with previous investigations using semaglutide injections. Additionally, the exenatide implant, delivered using NanoPortal technology, showed durable effects on body weight in healthy Sprague-Dawley rats over a period of 105 days, with some subjects observed for up to 112 days followed by a recovery period. These results highlight the potential of the exenatide implant in addressing obesity-related conditions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should no","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250617:nNDL6nLvhS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","VANI"],"gpt_icon":0},{"id":"2543547151","title":"Vivani Medical Inc. Unveils Presentation on Innovative Drug Implants for Chronic Disease Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2543547151","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543547151?lang=en_us&edition=fundamental","pubTime":"2025-06-13 04:42","pubTimestamp":1749760955,"startTime":"0","endTime":"0","summary":"Vivani Medical Inc. has released a presentation highlighting its innovative approach to treating chronic diseases through the development of ultra long-acting, miniature drug implants. The company's key programs include NPM-115, a high-dose exenatide implant, and NPM-139, a semaglutide implant, both aimed at chronic weight management with once or twice-yearly dosing. Additionally, the pipeline features NPM-119, an exenatide implant for type 2 diabetes, designed for twice-yearly dosing. Vivani anticipates significant milestones in 2025, including the completion of the LIBERATE-1 trial and progress in the NPM-139 program. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivani Me","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250612:nNDL1rMGyT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VANI","BK4082"],"gpt_icon":0},{"id":"2542627581","title":"Vivani Medical Appoints Anthony Baldor as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2542627581","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542627581?lang=en_us&edition=fundamental","pubTime":"2025-06-11 20:00","pubTimestamp":1749643202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250611:nTUA3DSMLF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VANI","BK4082"],"gpt_icon":0},{"id":"2542619581","title":"Vivani Medical Inc - Brigid a. Makes Retires as CFO of Vivani Medical","url":"https://stock-news.laohu8.com/highlight/detail?id=2542619581","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542619581?lang=en_us&edition=fundamental","pubTime":"2025-06-11 20:00","pubTimestamp":1749643202,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250611:nTUA3DSMLF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","VANI"],"gpt_icon":0},{"id":"2542581328","title":"Press Release: Vivani Medical Appoints Anthony Baldor as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2542581328","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542581328?lang=en_us&edition=fundamental","pubTime":"2025-06-11 20:00","pubTimestamp":1749643200,"startTime":"0","endTime":"0","summary":"ALAMEDA, Calif., June 11, 2025  -- Vivani Medical, Inc.  , a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today announced the appointment of Anthony Baldor as Chief Financial Officer. Baldor succeeds Brigid A. Makes, who has decided to retire from Vivani to focus on her board appointments and personal projects after a distinguished career and significant contributions to the Company.Baldor brings more than 20 years of financial management experience in the biotechnology sector, with a proven record in fundraising, business development and corporate strategy. Prior to joining Vivani, Baldor was Chief Financial Officer at Diakonos Oncology Corp., where he led the company's Series Seed and Series A financings, and Vice President of Corporate Strategy & Development at 4D Molecular Therapeutics, Inc., where he played a pivotal role in the company's Series C financing, initial public offering and various key partnership activities. His exper","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4099","BK4585","VANI","BK4604","CRGT","BK4082","BK4555","TM","03160","BK4588"],"gpt_icon":0},{"id":"2536686702","title":"Vivani Medical Price Target Maintained With a $4.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2536686702","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536686702?lang=en_us&edition=fundamental","pubTime":"2025-05-19 19:42","pubTimestamp":1747654920,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VANI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 19, 2025 07:42 ET (11:42 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VANI"],"gpt_icon":0},{"id":"2536402322","title":"Director and 10% Owner Gregg Williams Reports Acquisition of Common Shares in Vivani Medical Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2536402322","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536402322?lang=en_us&edition=fundamental","pubTime":"2025-05-17 08:11","pubTimestamp":1747440715,"startTime":"0","endTime":"0","summary":"Gregg Williams, a Director and 10% Owner, reported an acquisition of common shares of Vivani Medical Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivani Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 16, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250517:nNDL5RTtxk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","VANI"],"gpt_icon":0},{"id":"2535067875","title":"Vivani Medical Inc. Unveils Investor Presentation Highlighting Innovative Drug Implant Programs for Chronic Disease Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2535067875","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535067875?lang=en_us&edition=fundamental","pubTime":"2025-05-14 13:18","pubTimestamp":1747199883,"startTime":"0","endTime":"0","summary":"Vivani Medical Inc. Unveils Investor Presentation Highlighting Innovative Drug Implant Programs for Chronic Disease Management. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivani Medical Inc. published the original content used to generate this news brief on May 14, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nNDLbZ32dM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VANI","BK4082"],"gpt_icon":0},{"id":"2535087727","title":"Vivani Medical Q1 EPS $(0.11) Misses $(0.10) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2535087727","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535087727?lang=en_us&edition=fundamental","pubTime":"2025-05-14 04:46","pubTimestamp":1747169181,"startTime":"0","endTime":"0","summary":"Vivani Medical (NASDAQ:VANI) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.10) by 10 percent. This is a 8.33 percent increase over losses of $(0.12) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45392182/vivani-medical-q1-eps-0-11-misses-0-10-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VANI"],"gpt_icon":0},{"id":"2535087259","title":"BRIEF-Vivani Medical Q1 Basic EPS USD -0.11","url":"https://stock-news.laohu8.com/highlight/detail?id=2535087259","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535087259?lang=en_us&edition=fundamental","pubTime":"2025-05-14 04:43","pubTimestamp":1747169031,"startTime":"0","endTime":"0","summary":"BRIEF-Vivani Medical Q1 Basic EPS USD -0.11May 13 (Reuters) - Vivani Medical Inc VANI.O:VIVANI MEDICAL Q1 BASIC EPS USD -0.11VIVANI MEDICAL Q1 OPERATING EXPENSES USD 6.557 MILLIONVIVANI MEDICAL Q1 INC","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nPLXF00D2C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VANI"],"gpt_icon":0},{"id":"2535082456","title":"Vivani Medical Q1 Basic EPS USD -0.11","url":"https://stock-news.laohu8.com/highlight/detail?id=2535082456","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535082456?lang=en_us&edition=fundamental","pubTime":"2025-05-14 04:30","pubTimestamp":1747168200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nPLXF00D2C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VANI","BK4082"],"gpt_icon":0},{"id":"2535833087","title":"Press Release: Vivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2535833087","media":"Dow Jones","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535833087?lang=en_us&edition=fundamental","pubTime":"2025-05-14 04:30","pubTimestamp":1747168200,"startTime":"0","endTime":"0","summary":"Vivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial Results. All subjects in the NPM-115 cohort had successful insertions of a miniature, ultra long-acting GLP-1  implant in the on-going LIBERATE-1 study in obese or overweight individuals; top-line results are anticipated in mid-2025. Announced new $3M equity financing together with the previously reported $8.25M equity financing secures financial position into mid-2026. Promising pre-clinical data released for NPM-139  for chronic weight management in obese and overweight patients. Company plans to spin off Cortigent, Inc., a division that develops brain implant devices to help patients recover critical body functions, as an independent publicly traded company. On April 15, 2025, Vivani and Okava Pharmaceuticals, Inc. , a clinical-stage company focused on the treatment of age-related diseases in dogs and cats, announced an expansion of their collaboration focused on cats that","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","SG9999002232.USD","BK4206","LU1894683348.USD","BK4585","LU1093756325.SGD","BK6502","BK4604","BK6097","BK4082","BK4099","BK4555","SG9999002224.SGD","BK4215","LU0683600562.USD","CRGT","VANI","LU1894683264.USD","MMM","BK4534","BK4512","BK4588","03160","LU1093756168.USD","EQR","TM","LU0787776722.HKD","5OX.SI"],"gpt_icon":0},{"id":"2534456461","title":"Vivani Medical Inc  expected to post a loss of 10 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2534456461","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534456461?lang=en_us&edition=fundamental","pubTime":"2025-05-10 06:37","pubTimestamp":1746830226,"startTime":"0","endTime":"0","summary":"Vivani Medical Inc  expected to post a loss of10cents a share - Earnings Preview Vivani Medical Inc VANI.OQ VANI.O is expected to report resultson May 12 (estimated) for the period ending March 31 202","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nL8N3RH3OD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VANI"],"gpt_icon":0},{"id":"2531218863","title":"Director and 10% Owner Gregg Williams Reports Acquisition of Common Shares of Vivani Medical Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2531218863","media":"Reuters","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531218863?lang=en_us&edition=fundamental","pubTime":"2025-04-29 08:00","pubTimestamp":1745884810,"startTime":"0","endTime":"0","summary":"Gregg Williams, a Director and 10% Owner, reported an acquisition of common shares of Vivani Medical Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivani Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 28, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nNDL2c3sw4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VANI","BK4082"],"gpt_icon":0},{"id":"2527449400","title":"Vivani Medical, Okava Expand Weight-Loss Drug Collaboration to Include Dogs","url":"https://stock-news.laohu8.com/highlight/detail?id=2527449400","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527449400?lang=en_us&edition=fundamental","pubTime":"2025-04-15 23:07","pubTimestamp":1744729652,"startTime":"0","endTime":"0","summary":"Vivani Medical  and Okava Pharmaceuticals said Tuesday they have expanded their partnership in the development of OKV-119 as a treatment for weight management, diabetes and other cardiometabolic diseases to include dogs.The companies began the collaboration in 2019 to develop OKV-119 for cats.Financial terms of the collaboration were not disclosed.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4082","VANI"],"gpt_icon":0},{"id":"2527241215","title":"BRIEF-Vivani Medical And Okava Expand Collaboration To Develop Okv-119 For Dogs, Targeting Metabolic Health And Longevity","url":"https://stock-news.laohu8.com/highlight/detail?id=2527241215","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527241215?lang=en_us&edition=fundamental","pubTime":"2025-04-15 21:35","pubTimestamp":1744724107,"startTime":"0","endTime":"0","summary":"BRIEF-Vivani Medical And Okava Expand Collaboration To Develop Okv-119 For Dogs, Targeting Metabolic Health And LongevityApril 15 (Reuters) - Vivani Medical Inc VANI.O:VIVANI MEDICAL AND OKAVA EXPAND ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nTUAPHFCF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VANI","BK4082"],"gpt_icon":0},{"id":"2527641555","title":"Vivani Medical Inc - Financial Terms of Expanded Agreement Not Disclosed","url":"https://stock-news.laohu8.com/highlight/detail?id=2527641555","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527641555?lang=en_us&edition=fundamental","pubTime":"2025-04-15 20:30","pubTimestamp":1744720200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nTUAPHFCF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","VANI"],"gpt_icon":0},{"id":"2527413072","title":"Vivani Medical and Okava Expand Collaboration to Develop Okv-119 for Dogs, Targeting Metabolic Health and Longevity","url":"https://stock-news.laohu8.com/highlight/detail?id=2527413072","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527413072?lang=en_us&edition=fundamental","pubTime":"2025-04-15 20:30","pubTimestamp":1744720200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nTUAPHFCF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VANI","BK4082"],"gpt_icon":0},{"id":"2527241597","title":"Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity","url":"https://stock-news.laohu8.com/highlight/detail?id=2527241597","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527241597?lang=en_us&edition=fundamental","pubTime":"2025-04-15 20:30","pubTimestamp":1744720200,"startTime":"0","endTime":"0","summary":"Over half of all dogs in the United States today are overweight or obese, placing them at increased risk for chronic diseases, metabolic decline and shortened lifespansALAMEDA, Calif. and SAN FRANCISC","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/15/3061726/0/en/Vivani-Medical-and-Okava-Expand-Collaboration-to-Develop-OKV-119-for-Dogs-Targeting-Metabolic-Health-and-Longevity.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VANI","BK4082"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":56,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VANI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-13","symbol":"VANI","fiscalQuarterEnding":"2025/03","expectedEps":-0.1,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":-0.11},{"market":"US","date":"2025-03-31","symbol":"VANI","fiscalQuarterEnding":"2024/12","expectedEps":-0.1,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"pre","actualEps":-0.11},{"market":"US","date":"2024-11-13","symbol":"VANI","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":-0.11},{"market":"US","date":"2024-08-13","symbol":"VANI","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"post","actualEps":-0.1},{"market":"US","date":"2024-05-13","symbol":"VANI","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715572800000,"reportTimeType":"post","actualEps":-0.12}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VANI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VANI\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1732161600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VANI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VANI","date":"2025-06-16","current":-2.868773,"percent":0.636364,"low":-15.317797,"twenty":-4.961933,"median":-3.137717,"eighty":-2.62184,"high":-1.630678,"avg":-3.85991,"sd":1.837327,"marketCap":68130488},"quantilePoints":[{"date":"2022-09-02","current":-11.795262,"twenty":-15.051401,"median":-14.651806,"eighty":-12.93788,"marketCap":178556678},{"date":"2022-09-09","current":-9.449613,"twenty":-14.080497,"median":-10.454891,"eighty":-9.483122,"marketCap":143048247},{"date":"2022-09-16","current":-10.857003,"twenty":-11.60761,"median":-10.036026,"eighty":-9.422806,"marketCap":164353305},{"date":"2022-09-23","current":-8.142752,"twenty":-10.843599,"median":-9.58365,"eighty":-9.114521,"marketCap":123264979},{"date":"2022-09-30","current":-7.640113,"twenty":-10.722965,"median":-9.432859,"eighty":-8.410826,"marketCap":115656030},{"date":"2022-10-07","current":-7.439057,"twenty":-10.334258,"median":-9.047502,"eighty":-8.169559,"marketCap":112612450},{"date":"2022-10-14","current":-6.567816,"twenty":-9.804812,"median":-8.578373,"eighty":-7.559691,"marketCap":99423604},{"date":"2022-10-21","current":-6.534307,"twenty":-9.610458,"median":-8.377317,"eighty":-6.842593,"marketCap":98916341},{"date":"2022-10-28","current":-6.266233,"twenty":-9.570246,"median":-8.209771,"eighty":-6.608027,"marketCap":94858235},{"date":"2022-11-04","current":-6.165705,"twenty":-9.503228,"median":-7.77415,"eighty":-6.272935,"marketCap":93336445},{"date":"2022-11-11","current":-5.663066,"twenty":-9.442911,"median":-7.489321,"eighty":-6.205916,"marketCap":85727496},{"date":"2022-11-18","current":-6.897088,"twenty":-9.409402,"median":-7.539585,"eighty":-6.239426,"marketCap":70522720},{"date":"2022-11-25","current":-7.145184,"twenty":-9.382595,"median":-7.439057,"eighty":-6.266233,"marketCap":73059508},{"date":"2022-12-02","current":-6.847468,"twenty":-9.047502,"median":-7.095565,"eighty":-6.266233,"marketCap":70015362},{"date":"2022-12-09","current":-7.988713,"twenty":-9.047502,"median":-7.439057,"eighty":-6.266233,"marketCap":81684589},{"date":"2022-12-16","current":-5.110791,"twenty":-8.812937,"median":-7.39136,"eighty":-6.266233,"marketCap":52257843},{"date":"2022-12-23","current":-4.614598,"twenty":-8.633764,"median":-7.145184,"eighty":-6.199214,"marketCap":47184266},{"date":"2022-12-30","current":-4.216155,"twenty":-8.616258,"median":-6.996326,"eighty":-6.065177,"marketCap":43110183},{"date":"2023-01-06","current":-4.733684,"twenty":-8.571671,"median":-6.946707,"eighty":-5.830613,"marketCap":48401924},{"date":"2023-01-13","current":-5.855081,"twenty":-8.538661,"median":-6.883244,"eighty":-5.609451,"marketCap":59868208},{"date":"2023-01-20","current":-6.003939,"twenty":-8.49845,"median":-6.847468,"eighty":-5.67647,"marketCap":61390281},{"date":"2023-01-27","current":-6.103178,"twenty":-8.420868,"median":-6.835891,"eighty":-5.709979,"marketCap":62404997},{"date":"2023-02-03","current":-7.294042,"twenty":-8.382328,"median":-6.835891,"eighty":-5.740388,"marketCap":74581581},{"date":"2023-02-10","current":-5.855081,"twenty":-8.337106,"median":-6.74823,"eighty":-5.755843,"marketCap":59868208},{"date":"2023-02-17","current":-5.681414,"twenty":-8.276789,"median":-6.583594,"eighty":-5.740388,"marketCap":58092456},{"date":"2023-02-24","current":-5.21003,"twenty":-8.249982,"median":-6.4676,"eighty":-5.666736,"marketCap":53272558},{"date":"2023-03-03","current":-5.557365,"twenty":-8.111944,"median":-6.366761,"eighty":-5.512003,"marketCap":56824062},{"date":"2023-03-10","current":-5.309269,"twenty":-7.978789,"median":-6.300699,"eighty":-5.458127,"marketCap":54287273},{"date":"2023-03-17","current":-5.110791,"twenty":-7.939094,"median":-6.266233,"eighty":-5.368812,"marketCap":52257843},{"date":"2023-03-24","current":-4.88552,"twenty":-7.92917,"median":-6.24238,"eighty":-5.269573,"marketCap":49954439},{"date":"2023-03-31","current":-4.961933,"twenty":-7.889474,"median":-6.199214,"eighty":-5.170335,"marketCap":50735770},{"date":"2023-04-06","current":-4.451351,"twenty":-7.889474,"median":-6.103178,"eighty":-5.110791,"marketCap":45515059},{"date":"2023-04-14","current":-3.652946,"twenty":-7.841169,"median":-6.065177,"eighty":-5.011553,"marketCap":50735770},{"date":"2023-04-21","current":-3.579887,"twenty":-7.77415,"median":-6.003939,"eighty":-4.88552,"marketCap":49721054},{"date":"2023-04-28","current":-4.237418,"twenty":-7.690997,"median":-5.94273,"eighty":-4.763456,"marketCap":58853493},{"date":"2023-05-05","current":-5.338865,"twenty":-7.640113,"median":-5.897631,"eighty":-4.763456,"marketCap":74151500},{"date":"2023-05-12","current":-5.229163,"twenty":-7.559691,"median":-5.855081,"eighty":-4.763456,"marketCap":72627839},{"date":"2023-05-19","current":-4.023678,"twenty":-7.501933,"median":-5.855081,"eighty":-4.709867,"marketCap":65517550},{"date":"2023-05-26","current":-4.024074,"twenty":-7.44975,"median":-5.755843,"eighty":-4.56736,"marketCap":65524000},{"date":"2023-06-02","current":-4.117657,"twenty":-7.38182,"median":-5.730085,"eighty":-4.532825,"marketCap":67047814},{"date":"2023-06-09","current":-4.460795,"twenty":-7.341609,"median":-5.681414,"eighty":-4.479534,"marketCap":72635132},{"date":"2023-06-16","current":-4.616767,"twenty":-7.320735,"median":-5.557365,"eighty":-4.462971,"marketCap":75174822},{"date":"2023-06-23","current":-3.961685,"twenty":-7.26427,"median":-5.518388,"eighty":-4.381711,"marketCap":64508124},{"date":"2023-06-29","current":-3.649742,"twenty":-7.204727,"median":-5.507746,"eighty":-4.30418,"marketCap":59428744},{"date":"2023-07-07","current":-3.649742,"twenty":-7.125336,"median":-5.482937,"eighty":-4.261724,"marketCap":59428744},{"date":"2023-07-14","current":-3.961685,"twenty":-7.075717,"median":-5.458127,"eighty":-4.213206,"marketCap":64508124},{"date":"2023-07-21","current":-3.774519,"twenty":-7.026098,"median":-5.383698,"eighty":-4.098941,"marketCap":61460496},{"date":"2023-07-28","current":-3.899297,"twenty":-6.996326,"median":-5.309269,"eighty":-4.055269,"marketCap":63492248},{"date":"2023-08-04","current":-4.055269,"twenty":-6.976478,"median":-5.305784,"eighty":-4.024074,"marketCap":66031938},{"date":"2023-08-11","current":-3.71213,"twenty":-6.946707,"median":-5.229163,"eighty":-4.023836,"marketCap":60444620},{"date":"2023-08-18","current":-2.988542,"twenty":-6.926859,"median":-5.21003,"eighty":-3.967924,"marketCap":55900678},{"date":"2023-08-25","current":-2.62068,"twenty":-6.886013,"median":-5.11946,"eighty":-3.951783,"marketCap":49019813},{"date":"2023-09-01","current":-2.513364,"twenty":-6.860627,"median":-5.110791,"eighty":-3.930259,"marketCap":47012470},{"date":"2023-09-08","current":-2.526676,"twenty":-6.847468,"median":-5.078563,"eighty":-3.899297,"marketCap":47261483},{"date":"2023-09-15","current":-2.608182,"twenty":-6.845153,"median":-5.011553,"eighty":-3.899297,"marketCap":48786047},{"date":"2023-09-22","current":-2.55303,"twenty":-6.835891,"median":-4.985845,"eighty":-3.868102,"marketCap":47754425},{"date":"2023-09-29","current":-2.744025,"twenty":-6.835891,"median":-4.94159,"eighty":-3.811953,"marketCap":51326986},{"date":"2023-10-06","current":-2.716856,"twenty":-6.822487,"median":-4.891519,"eighty":-3.800394,"marketCap":50818799},{"date":"2023-10-13","current":-2.771193,"twenty":-6.764744,"median":-4.855748,"eighty":-3.674864,"marketCap":51835174},{"date":"2023-10-20","current":-2.798362,"twenty":-6.718458,"median":-4.788265,"eighty":-3.649454,"marketCap":52343362},{"date":"2023-10-27","current":-3.070048,"twenty":-6.658915,"median":-4.763456,"eighty":-3.617001,"marketCap":57425242},{"date":"2023-11-03","current":-2.825531,"twenty":-6.599372,"median":-4.741545,"eighty":-3.370093,"marketCap":52851550},{"date":"2023-11-10","current":-2.698925,"twenty":-6.580438,"median":-4.615683,"eighty":-3.134857,"marketCap":50483394},{"date":"2023-11-17","current":-1.794049,"twenty":-6.547711,"median":-4.614598,"eighty":-2.977674,"marketCap":48277859},{"date":"2023-11-24","current":-1.801141,"twenty":-6.480942,"median":-4.562994,"eighty":-2.907036,"marketCap":48468704},{"date":"2023-12-01","current":-1.801331,"twenty":-6.400894,"median":-4.539119,"eighty":-2.825531,"marketCap":48473807},{"date":"2023-12-08","current":-1.818396,"twenty":-6.387241,"median":-4.499481,"eighty":-2.798362,"marketCap":48933032},{"date":"2023-12-15","current":-1.668601,"twenty":-6.340719,"median":-4.456073,"eighty":-2.771193,"marketCap":44902052},{"date":"2023-12-22","current":-1.763408,"twenty":-6.301655,"median":-4.366782,"eighty":-2.771193,"marketCap":47453305},{"date":"2023-12-29","current":-2.028867,"twenty":-6.301655,"median":-4.301004,"eighty":-2.716856,"marketCap":54596814},{"date":"2024-01-05","current":-2.028867,"twenty":-6.300507,"median":-4.273208,"eighty":-2.716856,"marketCap":54596814},{"date":"2024-01-12","current":-1.971983,"twenty":-6.279637,"median":-4.250234,"eighty":-2.709684,"marketCap":53066062},{"date":"2024-01-19","current":-1.915288,"twenty":-6.266233,"median":-4.226786,"eighty":-2.63785,"marketCap":51540413},{"date":"2024-01-26","current":-1.953022,"twenty":-6.266233,"median":-4.21124,"eighty":-2.608182,"marketCap":52555811},{"date":"2024-02-02","current":-1.971983,"twenty":-6.260554,"median":-4.10206,"eighty":-2.583187,"marketCap":53066062},{"date":"2024-02-09","current":-1.915099,"twenty":-6.244311,"median":-4.059,"eighty":-2.580851,"marketCap":51535310},{"date":"2024-02-16","current":-1.990944,"twenty":-6.220601,"median":-4.055269,"eighty":-2.537218,"marketCap":53576313},{"date":"2024-02-23","current":-2.06679,"twenty":-6.201776,"median":-4.039471,"eighty":-2.526676,"marketCap":55617315},{"date":"2024-03-01","current":-8.0017,"twenty":-6.226663,"median":-4.024074,"eighty":-2.502279,"marketCap":215325753},{"date":"2024-03-08","current":-4.269974,"twenty":-6.201776,"median":-4.055269,"eighty":-2.516026,"marketCap":114904991},{"date":"2024-03-15","current":-3.738781,"twenty":-6.192512,"median":-4.054869,"eighty":-2.526676,"marketCap":100610590},{"date":"2024-03-22","current":-4.147391,"twenty":-6.1532,"median":-4.055269,"eighty":-2.526676,"marketCap":111606283},{"date":"2024-03-28","current":-3.964999,"twenty":-6.103178,"median":-4.055269,"eighty":-2.526676,"marketCap":101710160},{"date":"2024-04-05","current":-4.286449,"twenty":-6.065177,"median":-4.055269,"eighty":-2.526676,"marketCap":109956000},{"date":"2024-04-12","current":-4.393611,"twenty":-6.065177,"median":-4.07255,"eighty":-2.55303,"marketCap":112704900},{"date":"2024-04-19","current":-3.868521,"twenty":-6.065177,"median":-4.086099,"eighty":-2.553845,"marketCap":99235290},{"date":"2024-04-26","current":-3.632766,"twenty":-6.053559,"median":-4.055269,"eighty":-2.579112,"marketCap":93187710},{"date":"2024-05-03","current":-3.686378,"twenty":-6.003939,"median":-4.054869,"eighty":-2.580742,"marketCap":94562959},{"date":"2024-05-10","current":-3.686378,"twenty":-5.95432,"median":-4.027035,"eighty":-2.581014,"marketCap":94562959},{"date":"2024-05-17","current":-4.268615,"twenty":-5.95432,"median":-4.024808,"eighty":-2.581014,"marketCap":108307576},{"date":"2024-05-24","current":-3.5319,"twenty":-5.93114,"median":-4.024074,"eighty":-2.581014,"marketCap":89614897},{"date":"2024-05-31","current":-3.553568,"twenty":-5.909989,"median":-4.024074,"eighty":-2.581014,"marketCap":90164682},{"date":"2024-06-07","current":-3.488564,"twenty":-5.899045,"median":-4.023678,"eighty":-2.58536,"marketCap":88515328},{"date":"2024-06-14","current":-3.510232,"twenty":-5.874491,"median":-4.004377,"eighty":-2.598364,"marketCap":89065113},{"date":"2024-06-21","current":-2.708512,"twenty":-5.857471,"median":-3.98693,"eighty":-2.607058,"marketCap":68723081},{"date":"2024-06-28","current":-2.751848,"twenty":-5.855878,"median":-3.985865,"eighty":-2.607807,"marketCap":69822650},{"date":"2024-07-05","current":-2.62184,"twenty":-5.855081,"median":-3.965262,"eighty":-2.608182,"marketCap":66523942},{"date":"2024-07-12","current":-2.860189,"twenty":-5.855081,"median":-3.963325,"eighty":-2.608182,"marketCap":72571573},{"date":"2024-07-15","current":-2.903525,"twenty":-5.855081,"median":-3.961685,"eighty":-2.608182,"marketCap":73671143},{"date":"2024-08-02","current":-2.62184,"twenty":-5.855081,"median":-3.961685,"eighty":-2.608182,"marketCap":66523942},{"date":"2024-08-09","current":-2.513499,"twenty":-5.855081,"median":-3.961685,"eighty":-2.600172,"marketCap":63775019},{"date":"2024-08-16","current":-2.884876,"twenty":-5.855081,"median":-3.943309,"eighty":-2.581014,"marketCap":69822650},{"date":"2024-08-23","current":-3.082073,"twenty":-5.805462,"median":-3.930491,"eighty":-2.586447,"marketCap":74595405},{"date":"2024-08-30","current":-2.990752,"twenty":-5.755843,"median":-3.930297,"eighty":-2.600172,"marketCap":72385171},{"date":"2024-09-06","current":-2.785281,"twenty":-5.755843,"median":-3.903974,"eighty":-2.605081,"marketCap":67412144},{"date":"2024-09-13","current":-2.830941,"twenty":-5.735237,"median":-3.899297,"eighty":-2.607807,"marketCap":68517261},{"date":"2024-09-20","current":-2.808111,"twenty":-5.703277,"median":-3.899297,"eighty":-2.608182,"marketCap":67964702},{"date":"2024-09-27","current":-2.568394,"twenty":-5.684446,"median":-3.868521,"eighty":-2.608182,"marketCap":62162838},{"date":"2024-10-04","current":-2.556979,"twenty":-5.666736,"median":-3.868102,"eighty":-2.605081,"marketCap":61886558},{"date":"2024-10-11","current":-2.534149,"twenty":-5.578505,"median":-3.86779,"eighty":-2.590269,"marketCap":61334000},{"date":"2024-10-18","current":-2.876601,"twenty":-5.557365,"median":-3.847356,"eighty":-2.590269,"marketCap":69622378},{"date":"2024-10-25","current":-2.853771,"twenty":-5.534696,"median":-3.836405,"eighty":-2.598382,"marketCap":69069820},{"date":"2024-10-31","current":-3.059243,"twenty":-5.516259,"median":-3.813585,"eighty":-2.601652,"marketCap":74042847},{"date":"2024-11-08","current":-2.876601,"twenty":-5.507746,"median":-3.805714,"eighty":-2.60484,"marketCap":69622378},{"date":"2024-11-15","current":-3.391375,"twenty":-5.507746,"median":-3.799064,"eighty":-2.607432,"marketCap":79568432},{"date":"2024-11-22","current":-3.132311,"twenty":-5.477975,"median":-3.725455,"eighty":-2.608182,"marketCap":73490288},{"date":"2024-11-29","current":-3.635579,"twenty":-5.458127,"median":-3.707794,"eighty":-2.608182,"marketCap":85297952},{"date":"2024-12-06","current":-3.256873,"twenty":-5.458127,"median":-3.686378,"eighty":-2.609269,"marketCap":76412748},{"date":"2024-12-13","current":-3.28212,"twenty":-5.438279,"median":-3.666018,"eighty":-2.614811,"marketCap":77005095},{"date":"2024-12-20","current":-2.979155,"twenty":-5.408507,"median":-3.649742,"eighty":-2.621144,"marketCap":69896933},{"date":"2024-12-27","current":-3.004402,"twenty":-5.398583,"median":-3.649382,"eighty":-2.62184,"marketCap":70489279},{"date":"2025-01-03","current":-3.029649,"twenty":-5.358888,"median":-3.643482,"eighty":-2.62184,"marketCap":71081626},{"date":"2025-01-10","current":-3.080143,"twenty":-5.34287,"median":-3.635579,"eighty":-2.62184,"marketCap":72266320},{"date":"2025-01-17","current":-3.054896,"twenty":-5.315188,"median":-3.625669,"eighty":-2.624743,"marketCap":71673973},{"date":"2025-01-24","current":-3.029649,"twenty":-5.309269,"median":-3.617859,"eighty":-2.625469,"marketCap":71081626},{"date":"2025-01-31","current":-2.953908,"twenty":-5.309269,"median":-3.616417,"eighty":-2.631398,"marketCap":69304586},{"date":"2025-02-07","current":-2.928661,"twenty":-5.305086,"median":-3.579536,"eighty":-2.6391,"marketCap":68712239},{"date":"2025-02-14","current":-2.903414,"twenty":-5.276709,"median":-3.559838,"eighty":-2.645619,"marketCap":68119892},{"date":"2025-02-21","current":-2.979155,"twenty":-5.247455,"median":-3.553568,"eighty":-2.65505,"marketCap":69896933},{"date":"2025-02-28","current":-2.802425,"twenty":-5.22151,"median":-3.553568,"eighty":-2.667558,"marketCap":65750504},{"date":"2025-03-07","current":-2.751931,"twenty":-5.21003,"median":-3.5319,"eighty":-2.67113,"marketCap":64565811},{"date":"2025-03-14","current":-2.67619,"twenty":-5.21003,"median":-3.521066,"eighty":-2.656636,"marketCap":62788770},{"date":"2025-03-21","current":-2.777178,"twenty":-5.190182,"median":-3.493456,"eighty":-2.667558,"marketCap":65158157},{"date":"2025-03-28","current":-2.903414,"twenty":-5.144031,"median":-3.480309,"eighty":-2.67113,"marketCap":68119892},{"date":"2025-04-04","current":-2.496906,"twenty":-5.115992,"median":-3.458849,"eighty":-2.650943,"marketCap":58642342},{"date":"2025-04-11","current":-2.547702,"twenty":-5.110791,"median":-3.374618,"eighty":-2.63785,"marketCap":59835332},{"date":"2025-04-17","current":-2.648601,"twenty":-5.110791,"median":-3.357861,"eighty":-2.625696,"marketCap":62205048},{"date":"2025-04-25","current":-2.598152,"twenty":-5.110791,"median":-3.312934,"eighty":-2.623795,"marketCap":61020190},{"date":"2025-05-02","current":-2.623376,"twenty":-5.0979,"median":-3.294018,"eighty":-2.622147,"marketCap":61612619},{"date":"2025-05-09","current":-2.572927,"twenty":-5.039379,"median":-3.256873,"eighty":-2.620912,"marketCap":60427761},{"date":"2025-05-16","current":-2.569379,"twenty":-5.011553,"median":-3.231626,"eighty":-2.608725,"marketCap":61020190},{"date":"2025-05-23","current":-2.843779,"twenty":-5.011553,"median":-3.195963,"eighty":-2.608725,"marketCap":67536909},{"date":"2025-05-30","current":-2.993452,"twenty":-5.011553,"median":-3.178063,"eighty":-2.610899,"marketCap":71091483},{"date":"2025-06-06","current":-2.843827,"twenty":-5.009757,"median":-3.164628,"eighty":-2.62068,"marketCap":67538049},{"date":"2025-06-13","current":-2.968556,"twenty":-4.961933,"median":-3.143124,"eighty":-2.62184,"marketCap":70500244},{"date":"2025-06-16","current":-2.868773,"twenty":-4.961933,"median":-3.137717,"eighty":-2.62184,"marketCap":68130488}],"updateTime":1750172096967}}}